Innovating with physicians
since 2002.
We are inspired and honored to innovate with healthcare professionals and unlock the possible in stroke care.
Japanese engineering. American labs.
We are bicoastal, with corporate headquarters in New York City and a research and development team in the San Francisco Bay Area. In partnership with Kaneka Corporation in Japan, we design, develop and manufacture medical devices to treat neurovascular conditions.
Products are distributed in the U.S. by Kaneka Medical America LLC.
A history driven by innovation.
More than 40,000 clinical cases completed in Japan. Now the full system is in U.S. labs.
- 2002
Kaneka Corporation commercializes the ED Coil, the first neurovascular embolization coil developed in Japan.
- 2021
Twenty years on, the footprint reaches more than 20 countries, including the United States. Kaneka Neurovascular USA opens in New York City, with R&D in the San Francisco Bay Area.
- Jan 2026
WaveSelect 1014 launches in the U.S., built on more than 40,000 clinical cases in Japan.
- Now
SurfRider 13 reaches its first U.S. labs, and the complete system comes together with Toro 88.
"With people and technology growing together into creative fusion, we are breaking fresh ground for the future."
New York City
Corporate headquarters. 623 Fifth Avenue, Floor 27.
San Francisco Bay Area
Research and development.
Field team
Territory representatives across the U.S. Find yours